Lucida Medical announces that it has signed a distribution agreement with international medical imaging IT and cybersecurity company Sectra.
Through this agreement, the Lucida Pi application for diagnosing prostate cancer from MRI images will be offered through the Sectra Amplifier Marketplace. This greatly expands the availability of Pi to assist healthcare by improving the speed and accuracy of prostate cancer diagnosis.
